Jonathan Vu
Senior Consultant, Custom Insights
Expertise:
Jonathan Vu is a Senior Consultant of the Custom Insights practice at EVERSANA. Jonathan joined EVERSANA in 2019, bringing his expertise in global pricing and market access to the team. Jonathan has executed and lead numerous market access strategy engagements, including launch price and market access planning, clinical payer panel execution, health economics and outcomes research advisory board execution, patient services and manufacturer hub benchmarking and tracking, commercialization strategies, and long-range planning strategies. Jonathan has knowledge of both the US and ex-US markets, and expertise with payers, health systems, specialty pharmacies, healthcare providers, office practice managers, and employer stakeholders. Jonathan’s experience spans multiple therapeutic areas, including oncology, immunology, neurology, respiratory, virology, psychiatry, and hematology.
Prior to joining EVERSANA in 2019, Jonathan was at MKO Global Partners, a Two Labs Company, where he developed his understanding and expertise of pricing and market access of the pharmaceutical and biotech industry and bolstered his analytical abilities.
Articles by Jonathan Vu
The Pitfalls of Government Price Setting: Value Assessments in the U.S. vs. Germany
As the U.S. considers implementation of the drug pricing provisions of the Inflation Reduction Act (IRA), which includes price negotiation for a limited subset of drugs, it is important to understand the nuances of a government price setting system rooted in comparative effectiveness research. Germany, for example, assesses relative clinical benefit of medicines as part […]